A phase I study of [177Lu]Lu-EVS459 in patients with ovarian and lung cancers

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507674-41-00

Acronym

CGIZ943A12101

Enrollment

Registered

2024-11-05

Start date

Unknown

Completion date

2025-02-27

Last updated

2025-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced high-grade serous ovarian cancer (OC), Locally advanced unresectable or metastatic non-squamous non-small cell lung carcinoma (NSCLC)

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Italy, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026